RAPGEF3 and heart disorder: Animal and clinical studies have implicated EPAC1 and/or EPAC2 in diverse human diseases, notably cancer (reviewed in ref. 14), chronic inflammatory pain15, pathological angiogenesis16, and heart diseases (reviewed in refs. 12, 17).